Showing 38,141 - 38,160 results of 153,701 for search '(( 2 a decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (teer decrease)) ))', query time: 2.08s Refine Results
  1. 38141

    Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
  2. 38142

    Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
  3. 38143

    Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
  4. 38144

    Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
  5. 38145

    Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
  6. 38146

    Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…PDE7 inhibition suppressed the PI3K/AKT/mTOR pathway, upregulated the pro-apoptotic protein Bcl-2 Associated X-protein (BAX) in A2780, and increased IL-6 expression in OVCAR3. …”
  7. 38147
  8. 38148
  9. 38149

    Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly – A meta-analysis by Margit Solymár (3356882)

    Published 2018
    “…Our results also suggest that metformin treatment may reduce the risk of major coronary events (-4-5%) and all-cause mortality (-2%) in elderly diabetic populations.…”
  10. 38150

    Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus by Julia Diegelmann (107830)

    Published 2010
    “…All hepatic cell lines investigated as well as primary hepatocytes expressed both IFN-λ receptor subunits IL-10R2 and IFN-λR1. Both, IL-28A and IL-29 activated STAT1 signaling. …”
  11. 38151
  12. 38152
  13. 38153

    Bodyweight of mice in acute toxicity test. by Prapaporn Chaniad (9761710)

    Published 2024
    “…Ethanolic extracts of the CTLL and PSCD formulations demonstrated a significant dose-dependent decrease in parasitemia in mice. …”
  14. 38154

    DataSheet_1_Soshiho-Tang, a Traditional Herbal Medicine, Alleviates Atopic Dermatitis Symptoms via Regulation of Inflammatory Mediators.docx by Ji-Hyun Lee (145976)

    Published 2019
    “…SST and dexamethasone were administered orally for 14 day. As a result, SST treatment increased the expression of heme oxygenase-1 (HO-1), an anti-oxidative factor, and the nuclear translocation of NF-E2 p45-related factor 2 (Nrf2). …”
  15. 38155
  16. 38156
  17. 38157

    Table_2_Short-Term Changes in Mental, Physical, and Social Factors After Metabolic Bariatric Surgery in Adolescents: A Nationwide Prospective Cohort Study.docx by Ariela Goldenshluger (12533617)

    Published 2022
    “…</p>Methods<p>We followed 97 adolescents (64% females, aged 17 ± 0.9 years, BMI 46.1 ± 5.9 kg/m<sup>2</sup>) before and 9 months following MBS in a multi-center, prospective cohort study. …”
  18. 38158

    Supplementary Material for: An early phase 2 double-blind, placebo-controlled study of E6011, a novel anti-fractalkine antibody, in patients with Crohn’s disease by figshare admin karger (2628495)

    Published 2025
    “…Methods: In this early phase 2, double-blind, placebo-controlled study, we examined the efficacy and safety of E6011 in patients with moderate to severe active CD in a 12-week, double-blind period and the long-term efficacy and safety of E6011 in a subsequent open-label period for a maximum of 52 weeks. …”
  19. 38159

    SCS Design 2. by Matthew R. Lakin (649454)

    Published 2014
    “…<p>(a) Target structure. (b) MFE structure of the SCS Design 2 sequence from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110986#pone-0110986-t001" target="_blank">Table 1</a>. …”
  20. 38160

    OPJ: Origin data for Fig 4b. by Nacer Badi (14046883)

    Published 2024
    “…Thermal and dynamic flow patterns are analyzed for a variety of parameters: Rayleigh numbers from 10<sup>2</sup> to 10<sup>6</sup>, PV panel tilt angle from 15° to 90°, and channel aspect ratios from 1/20 to 1/5. …”